Financials

News Discussions Technicals Seasonals

CRNO_B fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Cereno Scientific AB is a research and development company, which engages in the discovery and development of drug for the preventive treatment of thrombosis related diseases. Its product pipeline include CS1, a reformulation of valproic acid that restores the body's balance between the systems and decreases the risk of blood clot in myocardial infarction or stroke. The company was founded by Claes Sverker Jern, Niklas Olof Bergh, and Pia Larsson in April 2012 and is headquartered in Molndal, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

CRNO_B has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company